Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cryptococcosis | 10 | 2014 | 28 | 0.890 |
Why?
|
| Organ Transplantation | 8 | 2014 | 110 | 0.580 |
Why?
|
| Endocarditis, Bacterial | 3 | 2011 | 32 | 0.530 |
Why?
|
| Nocardia Infections | 1 | 2011 | 8 | 0.390 |
Why?
|
| Staphylococcus aureus | 4 | 2018 | 175 | 0.380 |
Why?
|
| Staphylococcal Infections | 4 | 2021 | 156 | 0.330 |
Why?
|
| Cryptococcus neoformans | 4 | 2010 | 24 | 0.310 |
Why?
|
| Renal Dialysis | 3 | 2021 | 174 | 0.270 |
Why?
|
| Transplants | 3 | 2010 | 28 | 0.270 |
Why?
|
| Cryptococcus | 3 | 2011 | 7 | 0.210 |
Why?
|
| Anti-Bacterial Agents | 4 | 2021 | 1026 | 0.210 |
Why?
|
| Antigens, Fungal | 3 | 2011 | 19 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2324 | 0.190 |
Why?
|
| Endocarditis | 1 | 2021 | 14 | 0.190 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2021 | 31 | 0.190 |
Why?
|
| Catheters, Indwelling | 1 | 2021 | 72 | 0.190 |
Why?
|
| Dermatomycoses | 2 | 2010 | 17 | 0.180 |
Why?
|
| Calcineurin Inhibitors | 3 | 2014 | 24 | 0.180 |
Why?
|
| Antifungal Agents | 3 | 2010 | 108 | 0.180 |
Why?
|
| Central Nervous System Diseases | 2 | 2010 | 40 | 0.170 |
Why?
|
| Middle Aged | 17 | 2021 | 21147 | 0.160 |
Why?
|
| Babesia | 1 | 2017 | 5 | 0.150 |
Why?
|
| Babesiosis | 1 | 2017 | 9 | 0.150 |
Why?
|
| Prospective Studies | 9 | 2011 | 3705 | 0.150 |
Why?
|
| Immunosuppressive Agents | 4 | 2010 | 514 | 0.150 |
Why?
|
| Bacteremia | 1 | 2018 | 155 | 0.140 |
Why?
|
| Aged | 10 | 2021 | 14862 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2017 | 205 | 0.130 |
Why?
|
| Male | 17 | 2021 | 37321 | 0.120 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2014 | 1 | 0.120 |
Why?
|
| Immunocompromised Host | 2 | 2011 | 55 | 0.120 |
Why?
|
| Liver Transplantation | 1 | 2017 | 400 | 0.120 |
Why?
|
| Female | 16 | 2021 | 38074 | 0.110 |
Why?
|
| Postoperative Complications | 3 | 2010 | 1615 | 0.110 |
Why?
|
| Transplant Recipients | 1 | 2014 | 109 | 0.110 |
Why?
|
| Algorithms | 1 | 2018 | 1196 | 0.110 |
Why?
|
| Cohort Studies | 6 | 2021 | 2358 | 0.100 |
Why?
|
| Lung Diseases, Fungal | 2 | 2010 | 6 | 0.100 |
Why?
|
| Meningitis, Cryptococcal | 2 | 2008 | 4 | 0.100 |
Why?
|
| Antibodies, Fungal | 1 | 2011 | 9 | 0.100 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2011 | 22 | 0.100 |
Why?
|
| Glucosylceramides | 1 | 2011 | 32 | 0.100 |
Why?
|
| Humans | 20 | 2021 | 68618 | 0.100 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 47 | 0.100 |
Why?
|
| Equipment Contamination | 1 | 2011 | 38 | 0.100 |
Why?
|
| Pacemaker, Artificial | 1 | 2011 | 157 | 0.090 |
Why?
|
| Adult | 11 | 2018 | 21403 | 0.090 |
Why?
|
| Amphotericin B | 1 | 2009 | 26 | 0.090 |
Why?
|
| Southeastern United States | 1 | 2010 | 281 | 0.090 |
Why?
|
| Cytomegalovirus Infections | 1 | 2010 | 69 | 0.090 |
Why?
|
| Tissue Donors | 1 | 2010 | 195 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 2 | 2021 | 365 | 0.080 |
Why?
|
| Transplantation Immunology | 1 | 2008 | 11 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2010 | 211 | 0.080 |
Why?
|
| Lipids | 1 | 2009 | 298 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 4848 | 0.070 |
Why?
|
| Tacrolimus | 1 | 2007 | 127 | 0.070 |
Why?
|
| Comorbidity | 1 | 2010 | 1426 | 0.070 |
Why?
|
| Cross Infection | 1 | 2005 | 195 | 0.060 |
Why?
|
| Lamivudine | 1 | 2002 | 24 | 0.050 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2002 | 28 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2011 | 7277 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2002 | 135 | 0.050 |
Why?
|
| Child | 1 | 2011 | 6405 | 0.040 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 92 | 0.040 |
Why?
|
| HIV Infections | 2 | 2011 | 791 | 0.040 |
Why?
|
| Fungemia | 2 | 2010 | 13 | 0.040 |
Why?
|
| Coagulase | 1 | 2018 | 14 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 38 | 0.040 |
Why?
|
| Staphylococcus | 1 | 2018 | 29 | 0.040 |
Why?
|
| Adolescent | 1 | 2011 | 8912 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2018 | 242 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 249 | 0.040 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 2017 | 13 | 0.040 |
Why?
|
| Clindamycin | 1 | 2017 | 25 | 0.040 |
Why?
|
| Quinidine | 1 | 2017 | 15 | 0.040 |
Why?
|
| Blood Donors | 1 | 2017 | 18 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 567 | 0.040 |
Why?
|
| Antimalarials | 1 | 2017 | 71 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 450 | 0.040 |
Why?
|
| Risk Factors | 2 | 2014 | 5731 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2009 | 7029 | 0.030 |
Why?
|
| Climate | 1 | 2010 | 9 | 0.020 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2010 | 2 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2011 | 172 | 0.020 |
Why?
|
| Fluconazole | 1 | 2010 | 26 | 0.020 |
Why?
|
| Transplantation | 1 | 2010 | 23 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2010 | 34 | 0.020 |
Why?
|
| Ganciclovir | 1 | 2010 | 27 | 0.020 |
Why?
|
| Acyclovir | 1 | 2010 | 38 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 507 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2010 | 152 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 1619 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 2010 | 63 | 0.020 |
Why?
|
| Drug Compounding | 1 | 2009 | 34 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2010 | 106 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2008 | 23 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 546 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 649 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 737 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 1753 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2007 | 260 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2007 | 226 | 0.020 |
Why?
|
| Patient Selection | 1 | 2010 | 592 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1465 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2005 | 45 | 0.020 |
Why?
|
| South Carolina | 1 | 2011 | 2752 | 0.020 |
Why?
|
| Global Health | 1 | 2005 | 136 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2010 | 2007 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2005 | 384 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 2093 | 0.010 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2002 | 14 | 0.010 |
Why?
|
| Half-Life | 1 | 2002 | 96 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 4655 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2002 | 238 | 0.010 |
Why?
|
| United States | 1 | 2010 | 7367 | 0.010 |
Why?
|